Klotz, Laurence. “Sunitinib, Sorafenib and Other Systemic Noncytotoxic Kidney Cancer Therapies Can and Should Be Administered by Urologists”. Canadian Urological Association Journal, vol. 1, no. 2S, Dec. 2012, doi:10.5489/cuaj.70.